
KCAS Bio is excited to expand our global reach by attending key conferences across Europe in 2025. These events bring together top experts in biotechnology, pharmaceuticals, and clinical research, providing a unique opportunity to discuss cutting-edge advancements, regulatory insights, and innovative solutions in bioanalytical and biomarker services. As we continue…

KCAS Bio is pleased to announce its participation in the EBF Spring Focus Workshop, taking place June 12–13, 2025, in Málaga, Spain. This specialized event, organized by the European Bioanalysis Forum (EBF), offers a unique platform for industry leaders, scientists, and regulatory experts to discuss the latest advancements and challenges…

KCAS Bio is excited to announce our participation in the Healthtech Accelerations Summit (HAS) 2025, taking place on June 26 in Paris, France. This prestigious event brings together global leaders in biotechnology, pharmaceuticals, and digital health to discuss the latest breakthroughs, investment opportunities, and regulatory advancements shaping the future of…

KCAS Bio is excited to announce our participation in Swiss Biotech Day 2025, taking place in Basel, Switzerland, on May 5-6. As one of the leading biotechnology conferences in Europe, this event brings together industry leaders, investors, and scientific pioneers to discuss the latest developments shaping the future of biotech…

Dom and John, the hosts of “The Weekly Bioanalysis”, recently returned from EBF in Barcelona where there was a session on Patient-centric Microsampling, which both of them found fascinating. This inspired both of them to decide it was high time to revisit this part of our industry. In spite of…

Antibody drug conjugates (ADCs) are important targeted therapies in oncology. These are complex moieties consisting of a cell-targeting antibody combined with an active payload through a chemical linker. Key Components to Monitor in PK Studies Two significant components to monitor for PK studies are the (1) intact antibody drug conjugate…

KCAS Bio launched an initiative to advance its Quality System through a 21 CFR Part 11 compliant electronic Quality Management System (eQMS) to be prepared for anticipated future regulatory requirements for Good Laboratory Practice (21 CFR 58). This was driven by the proposed rule from August 2016, the FDA is…

KCAS Bio is thrilled to announce our participation in several key scientific and bioanalytical events across the United States in the coming months. These conferences provide a unique platform to showcase our cutting-edge capabilities, engage with industry leaders, and explore innovative approaches to bioanalysis. From gene therapy to toxicology and…

KCAS Bio will be exhibiting at the AAPS Summer Scientific Forum, taking place in Indianapolis, Indiana, from July 14th – 17th. This annual event, hosted by the American Association of Pharmaceutical Scientists, is a cornerstone gathering for pharmaceutical and biopharmaceutical professionals dedicated to advancing innovation and excellence in the industry.

KCAS Bio is excited to announce our participation in the BIO International Convention, taking place in Boston, Massachusetts, from June 16 – 19, 2025. This premier event is a global gathering of leaders and innovators in biotechnology and life sciences, fostering collaboration and driving advancements in health, agriculture, and sustainability.

KCAS Bio is thrilled to announce our participation in the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), taking place in Baltimore, Maryland, from May 31 – June 5, 2025. This prestigious event is a cornerstone in the field of mass spectrometry, bringing together experts, innovators, and visionaries to…

KCAS Bio is excited to announce our participation in the inaugural PBSS Seminar Luncheon in Seattle, Washington, on April 1, 2025. This milestone event, titled “Building the Science That Builds Biotech Companies in the Pacific Northwest,” marks a new chapter in the PBSS journey and provides a platform for discussing…